Pharmaceutical Strategies Group (PSG) is pleased to present the 2022 Trends in Drug Benefit Design Report, which details traditional (non-specialty) drug benefit trends and strategies. This annual report, previously published under the Pharmacy Benefit Management Institute (PBMI) brand and first conducted in 1995, demonstrates PSG’s ongoing commitment to generating meaningful conversations and providing valuable insights about drug benefit design and management.
Back
2022 Trends in Benefit Design Report
Preview the 2022 Trends in Drug Benefit Design Report
About the Researchers
Morgan Lee, PhD, MPH, CPH
Morgan Lee is a dynamic behavioral scientist and research leader with over 15 years of quantitative and qualitative research and evaluation experience in health and…
Learn More
Rebekah Gregg, MBA
When Rebekah Gregg began working at a hospice provider after college, she found more than a job—she found a calling. Ever since then, Rebekah’s passion…
Learn More
Michael Lonergan, RPh
How many people started their career in pharmacy at the age of 14? Michael (Mike) Lonergan began working in his small-town drug store as a…
Learn More
Sharon Phares, PhD, MPH
Sharon Phares has more than 20 years of analytical and technical experience, with proven proficiency in data extraction, business intelligence, and business software tools. Before…
Learn More